Re: Name Confusion
in response to
by
...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
Message: Re: Name Confusion
Sorry i forgot the information.
Hi there
I do not write here offently but i read almost evething.
FYI this the naming at my RBC account, since the beginning at the split i think in 2013.
ZENE (Zenith Capital Corp Com)
Dernier cours: 1,345
New Message
Please
login
to post a reply